![](/img/cover-not-exists.png)
A theoretical dose-escalation study based on biological effective dose in radioimmunotherapy with90Y-ibritumomab tiuxetan (Zevalin)
Massimiliano Pacilio, Margherita Betti, Francesco Cicone, Carolina Del Mastro, Livia Montani, Laura Chiacchiararelli, Alessia Monaco, Enrico Santini, Francesco ScopinaroVolume:
37
Language:
english
Pages:
12
DOI:
10.1007/s00259-009-1333-4
Date:
May, 2010
File:
PDF, 423 KB
english, 2010